Clinical trials
Phase 1/2 Muscular Dystrophy, Duchenne trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2010 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarepta Therapeutics, Inc. | 4 |
| Cooperative International Neuromuscular Research Group | 2 |
| Craig McDonald, MD | 2 |
| Kevin Flanigan | 2 |
| Solid Biosciences Inc. | 2 |
| Avidity Biosciences, Inc. | 1 |
| Catabasis Pharmaceuticals | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Children's National Research Institute | 1 |
| Dyne Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Dystrophy, Duchenne | 25 |
| Muscular Dystrophies | 4 |
| Neuromuscular Diseases | 2 |
| Cardiomyopathies | 1 |
| Muscular Diseases | 1 |
| Muscular Dystrophies, Limb-Girdle | 1 |
| Muscular Dystrophy, Facioscapulohumeral | 1 |
| Musculoskeletal Diseases | 1 |
| Nervous System Diseases | 1 |
| Obesity | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.